faculty news
University of Minnesota Appointments/Elections • Kerry K. Fierke joined the Department of Pharmacy Practice and Pharmaceutical Sciences as an assistant professor. • Vishal Lamba joined the Department of Experimental and Clinical Pharmacology as an assistant professor.
Grants • Lowell J. Anderson, Tom Larson and Randy Seifert received a $10,000 grant from McKesson to support a new advanced practice experience rotation in rural community pharmacy marketing of MTM and other pharmaceutical care services. • Angela K. Birnbaum is a co-investigator on the four-year NIH grant, “Preclinical Studies of a Heroin/Morphine Vaccine, 1R01DA030715-01.” The funder is the National Institute on Drug Abuse. • Jim Cloyd received a $433,000 grant from Neurelis for his study, “A Three-Period, Three-Treatment, Six Sequence Randomized Crossover Study of the Bioavailability and Pharmacokinetics of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers.” • Dan Harki received a Minnesota Partnership for Biotechnology and Medical Genomics grant in the amount of $434,256 for his project, “Development of Antibodies for the Detection of Topoisomerase I- and Topoisomerase II- DNA Complexes.” He also received a $30,000 Leukemia Research Fund grant for his study, “Elucidating the Mechanisms of AML Cancer Stem Cell Toxicity by Parthenolide.” • Chengguo (Chris) Xing received a $30,000 Leukemia Research Fund grant for his study, “An Anticancer Agent Selective Against Drug-Resistant AML.” He also received a Danny Thompson Memorial Golf Tournament/Leukemia Research Fund Award for his project, “Novel Anticancer Agents for Treatment of Drug-Resistant Acute Myeloid Leukemia.”
46
academic Pharmacy now Jul/Aug/Sept 2011
University of North Carolina at Chapel Hill Appointments/Elections • S. Rahima Benhabbour, research assistant professor • Dalesha Carpenter, research assistant professor
Grants • Moo Cho, “New Chemical Entities for Targeted Release of Generic Chemotherapies,” NC Biotechnology Center, $100,000; and “New Chemical Entities for Targeted Release of Generic Chemotherapies,” NovoLipid Inc., $20,000. • Julie Dumond, “Optimizing Antiretroviral Use in Aging: Pharmacokinetics, Response, and Toxicity,” National Institute of Allergy and Infectious Diseases, $108,119. • Rudolph L. Juliano, “Intracellular Trafficking of Antisense and siRNA Oligonucleotides in Cancer Cells,” National Cancer Institute, $307,100. • Kuo-Hsiung Lee, “Plant Antitumor Agents,” National Cancer Institute, $312,243. • Herb Patterson, “Comparison of the Relative Oral Bioavailability of Tolvaptan Administered via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact,” Otsuka America Pharmaceutical, Inc. $174,425. • Scott F. Singleton, “Synereca Sponsored Research Amendment,” Synereca Pharmaceuticals, Inc. $43,558. • Alexander Tropsha, “Development, Validation, and Delivery of Externally Predictive QSAR Models of Hepatotoxicity;” U.S. Environmental Protection Agency; $750,000. • Xiao Xiao, “Muscle as a Platform for Type 2 Diabetes Treatment by Gene Delivery,” National Institute of Diabetes, Digestive and Kidney Diseases, $321,900.